ARTICLE | Product Development
Asymptomatic COVID-19 testing pushes forward, with lessons from cancer
As broad COVID-19 screening gains momentum, early cancer detection provides a playbook
August 8, 2020 3:23 AM UTC
The growing demand for asymptomatic COVID-19 testing is shifting the conversation from one-time diagnosis to ongoing screening, and from single results to population outcomes. Companies moving the ball forward for early detection of cancer, some of which have jumped into COVID-19 testing, offer clues to what will be needed for broad uptake.
While diagnostic testing aims to classify disease in sick patients, screening seeks to uncover issues in seemingly healthy individuals. The same test could be used either way or tuned to serve one purpose over the other. ...